Shinya Goto
#159,073
Most Influential Person Now
Researcher
Shinya Goto's AcademicInfluence.com Rankings
Shinya Gotocomputer-science Degrees
Computer Science
#8986
World Rank
#9444
Historical Rank
Computational Linguistics
#2094
World Rank
#2116
Historical Rank
Machine Learning
#3821
World Rank
#3867
Historical Rank
Artificial Intelligence
#4144
World Rank
#4202
Historical Rank
Download Badge
Computer Science
Shinya Goto's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Shinya Goto Influential?
(Suggest an Edit or Addition)Shinya Goto's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Apixaban versus warfarin in patients with atrial fibrillation. (2011) (6217)
- Rivaroxaban in patients with a recent acute coronary syndrome. (2012) (1745)
- International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. (2006) (1519)
- Long-term use of ticagrelor in patients with prior myocardial infarction. (2015) (1399)
- One-year cardiovascular event rates in outpatients with atherothrombosis. (2007) (987)
- Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. (2010) (626)
- Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –. (2012) (567)
- Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry (2013) (431)
- Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus. (2019) (386)
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (2019) (377)
- β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. (2012) (376)
- Metformin use and mortality among patients with diabetes and atherothrombosis. (2010) (355)
- Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. (1998) (316)
- Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry (2009) (276)
- Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial (2012) (264)
- Basic principles of platelet biology and clinical implications. (2010) (262)
- The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. (2006) (260)
- Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI (2014) (257)
- Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry (2015) (254)
- Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. (2008) (251)
- Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. (2014) (246)
- Platelet thrombin receptor antagonism and atherothrombosis (2009) (226)
- Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation (2016) (220)
- Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. (2009) (215)
- Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF (2016) (214)
- Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome -- randomized, double-blind, phase III PHILO study. (2015) (199)
- A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study. (2008) (198)
- International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). (2012) (196)
- Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding. (2005) (185)
- Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. (2012) (182)
- An international model to predict recurrent cardiovascular disease. (2012) (181)
- Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. (2014) (179)
- Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (2015) (166)
- Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial (2017) (166)
- Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease (2010) (150)
- Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes: The Lessons From Antagonizing the Cellular Effects of Thrombin–Acute Coronary Syndromes Trial (2011) (147)
- Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54. (2016) (145)
- Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. (1999) (141)
- Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial. (2015) (139)
- Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. (2014) (134)
- Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. (2019) (134)
- Involvement of Glycoprotein VI in Platelet Thrombus Formation on Both Collagen and von Willebrand Factor Surfaces Under Flow Conditions (2002) (129)
- Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis. (2013) (129)
- Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease: The Lessons From Antagonizing the Cellular Effect of Thrombin–Coronary Artery Disease Trial (2011) (123)
- Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry (2016) (122)
- Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis. (2012) (122)
- Functional Significance of Adenosine 5′-Diphosphate Receptor (P2Y12) in Platelet Activation Initiated by Binding of von Willebrand Factor to Platelet GP Ib&agr; Induced by Conditions of High Shear Rate (2002) (114)
- Safety and exploratory efficacy of the novel thrombin receptor (PAR-1) antagonist SCH530348 for non-ST-segment elevation acute coronary syndrome. (2010) (111)
- Impact of Diabetes on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years from the REACH Registry (2015) (109)
- Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. (2013) (104)
- Enhanced shear-induced platelet aggregation in acute myocardial infarction. (1999) (102)
- Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling. (2006) (101)
- The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease (2020) (95)
- Why do we need observational studies of everyday patients in the real-life setting? (2015) (95)
- Different effects of various anti‐GPIIb‐IIIa agents on shear‐induced platelet activation and expression of procoagulant activity (2003) (91)
- Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry. (2011) (88)
- ST-segment elevation myocardial infarction (2019) (88)
- Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (2015) (87)
- Efficacy and Safety of Vorapaxar in Patients With Prior Ischemic Stroke (2013) (87)
- Epinephrine Augments von Willebrand Factor‐Dependent Shear‐Induced Platelet Aggregation (1992) (86)
- Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions. (2004) (84)
- Risk Factor Profile and Management of Cerebrovascular Patients in the REACH Registry (2008) (84)
- Lnk regulates integrin alphaIIbbeta3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo. (2010) (84)
- Platelets, after Exposure to a High Shear Stress, Induce IL-10-Producing, Mature Dendritic Cells In Vitro1 (2004) (82)
- Predictors of Long‐term Adherence to Evidence‐based Cardiovascular Disease Medications in Outpatients With Stable Atherothrombotic Disease: Findings From the REACH Registry (2013) (81)
- Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial (2019) (78)
- Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation (2017) (78)
- Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials. (2009) (77)
- Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan. (2007) (77)
- Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation (2018) (77)
- A History of Stroke/Transient Ischemic Attack Indicates High Risks of Cardiovascular Event and Hemorrhagic Stroke in Patients With Coronary Artery Disease (2013) (70)
- High cardiovascular event rates in patients with asymptomatic carotid stenosis: the REACH registry * (2009) (70)
- Carotid Atherosclerosis and Risk of Subsequent Coronary Event in Outpatients With Atherothrombosis (2013) (70)
- Apixaban Compared with Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the ARISTOTLE Trial (2015) (69)
- Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells (2008) (69)
- Plasma Concentration of von Willebrand Factor in Acute Myocardial Infarction (2000) (68)
- Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry. (2010) (68)
- Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (2015) (67)
- Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry. (2016) (67)
- Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry (2008) (65)
- Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry. (2011) (64)
- Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan. (2009) (64)
- Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants. (2020) (63)
- Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. (2013) (62)
- Detection of von Willebrand factor and tissue factor in platelets-fibrin rich coronary thrombi in acute myocardial infarction. (2006) (61)
- The diagnosis and treatment of venous thromboembolism in asian patients (2018) (60)
- Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). (2010) (60)
- Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classifications. (2010) (59)
- Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine 'Chuanxiong,' on platelet thrombus formation under high shear rates. (2001) (59)
- Rivaroxaban vs. warfarin in Japanese patients with non-valvular atrial fibrillation in relation to age. (2014) (58)
- Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry (2018) (58)
- Co‐localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction (2006) (56)
- Attained Educational Level and Incident Atherothrombotic Events in Low- and Middle-Income Compared With High-Income Countries (2010) (56)
- Platelet receptors as therapeutic targets: Past, present and future (2017) (56)
- Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation: Results From the GARFIELD-AF Registry (2019) (53)
- Artificial intelligence to predict needs for urgent revascularization from 12-leads electrocardiography in emergency patients (2019) (52)
- Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry. (2010) (52)
- Disturbed blood flow induces erosive injury to smooth muscle cell‐rich neointima and promotes thrombus formation in rabbit femoral arteries (2010) (52)
- Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation (2016) (51)
- NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease. (2014) (50)
- World heart federation expert consensus statement on antiplatelet therapy in east asian patients with ACS or undergoing PCI. (2014) (50)
- Global Anticoagulant Registry in the Field – Venous Thromboembolism (GARFIELD-VTE) (2016) (50)
- Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: Results from 1-year outcomes in the Japanese REACH Registry (2009) (49)
- Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study (2013) (48)
- Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER* study (2013) (48)
- Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry (2016) (47)
- Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry. (2009) (46)
- Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report (2016) (42)
- Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial (2018) (42)
- Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH Registry (2012) (42)
- One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. -Results From the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE).-. (2008) (38)
- Vitamin K antagonists with or without long‐term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events (2017) (38)
- Coronary thrombosis. Effects of blood flow on the mechanism of thrombus formation. (1998) (37)
- Synergistic effect of epinephrine and shearing on platelet activation. (1996) (37)
- Safety of the novel protease-activated receptor-1 antagonist vorapaxar in Japanese patients with a history of ischemic stroke. (2012) (37)
- Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry (2019) (37)
- Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54) (2016) (36)
- Randomized, double-blind trial to evaluate the safety of apixaban with antiplatelet therapy after acute coronary syndrome in Japanese patients (APPRAISE-J). (2013) (35)
- Ethnic differences in the relationships of anthropometric measures to metabolic risk factors in Asian patients at risk of atherothrombosis: results from the REduction of Atherothrombosis for Continued Health (REACH) Registry. (2010) (35)
- 2018 update of expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. (2019) (34)
- New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 °P-TIMI 50 trial. (2014) (32)
- Late Outcomes After Carotid Artery Stenting Versus Carotid Endarterectomy: Insights From a Propensity-Matched Analysis of the Reduction of Atherothrombosis for Continued Health (REACH) Registry (2010) (32)
- Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry (2019) (32)
- ADAMTS-13 attenuates thrombus formation on type I collagen surface and disrupted plaques under flow conditions. (2009) (32)
- Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation for the secondary prevention of stroke: a subgroup analysis of J-ROCKET AF. (2013) (31)
- Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE (2020) (30)
- Risk factors and outcomes for patients with vascular disease and serious bleeding events (2011) (30)
- Evidence-Based Carotid Interventions for Stroke Prevention: State-of-the-art Review (2017) (30)
- Characterization of a patient with glycoprotein (GP) VI deficiency possessing neither anti‐GPVI autoantibody nor genetic aberration (2006) (28)
- One-year atherothrombotic vascular events rates in outpatients with recent non-cardioembolic ischemic stroke: the EVEREST (Effective Vascular Event REduction after STroke) registry. (2012) (28)
- Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry (2014) (28)
- Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes and Angiogenesis to Ameliorate Cardiac Function after Myocardial Infarction (2015) (28)
- Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients (2019) (27)
- Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial (2022) (27)
- Important regulatory role of activated platelet-derived procoagulant activity in the propagation of thrombi formed under arterial blood flow conditions. (2009) (27)
- Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure. (2014) (26)
- Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group (2020) (26)
- New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? (2021) (26)
- Standard dose versus low dose non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of contemporary randomized controlled trials. (2016) (26)
- Platelets: Small in Size But Essential in the Regulation of Vascular Homeostasis - Translation From Basic Science to Clinical Medicine. (2015) (26)
- Role of von Willebrand factor for the onset of arterial thrombosis. (2001) (25)
- Understanding the mechanism and prevention of arterial occlusive thrombus formation by anti-platelet agents. (2004) (24)
- Left ventricular ejection performance in mitral stenosis, and effects of successful percutaneous transvenous mitral commissurotomy. (1992) (24)
- Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry (2019) (23)
- Circadian variations of gastrointestinal mucosal damage detected with transnasal endoscopy in apparently healthy subjects treated with low-dose aspirin (ASA) for a short period. (2009) (22)
- Antiplatelet therapy after coronary intervention in Asia and Japan (2009) (22)
- Understanding the mechanism of platelet thrombus formation under blood flow conditions and the effect of new antiplatelet agents. (2004) (21)
- Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry. (2019) (21)
- Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation (2019) (21)
- Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE. (2010) (21)
- Functional compensation of the low platelet count by increased individual platelet size in a patient with May-Hegglin anomaly presenting with acute myocardial infarction. (1998) (21)
- Interaction between diabetes and a high ankle–brachial index on mortality risk (2015) (20)
- Two distinct mechanisms are involved in stent thrombosis under flow conditions. (2001) (20)
- Prediction of Molecular Interaction between Platelet Glycoprotein Ibα and von Willebrand Factor using Molecular Dynamics Simulations. (2016) (20)
- Application of Ex Vivo Flow Chamber System for Assessment of Stent Thrombosis (2002) (20)
- Acute myocardial infarction plasma augments platelet thrombus growth in high shear rates (1997) (20)
- Enhanced shear-induced von Willebrand factor binding to platelets in acute myocardial infarction. (2000) (20)
- Propagation of arterial thrombi: local and remote contributory factors. (2004) (20)
- History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. (2016) (19)
- Imaging of structural changes in endothelial cells and thrombus formation at the site of FeCl(3)-induced injuries in mice cremasteric arteries. (2009) (19)
- A role for glycosphingolipid‐enriched microdomains in platelet glycoprotein Ib‐mediated platelet activation (2007) (19)
- Effects of adenosine 5'-diphosphate (ADP) receptor blockade on platelet aggregation under flow. (2002) (19)
- Shear-induced von Willebrand factor-mediated platelet surface translocation of the CD40 ligand. (2002) (18)
- Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation (2020) (18)
- Platelet surface P-selectin molecules increased after exposing platelet to a high shear flow. (2000) (18)
- A Modified Essen Stroke Risk Score for Predicting Recurrent Cardiovascular Events: Development and Validation (2013) (18)
- Rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation in relation to the CHADS2 score: a subgroup analysis of the J-ROCKET AF trial. (2014) (17)
- Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program (2012) (17)
- New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome (2014) (17)
- Development of virtual platelets implementing the functions of three platelet membrane proteins with different adhesive characteristics. (2015) (17)
- Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry. (2021) (17)
- A pheochromocytoma causing limited coagulopathy with hemoptysis. (2005) (17)
- Burden of nonsteroidal anti-inflammatory and antiplatelet drug use in Asia: a multidisciplinary working party report. (2012) (16)
- The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events (2019) (16)
- Cardiovascular risk factors in patients at high risk of atherothrombosis: What can be learned from registries? (2008) (16)
- [Enhanced shear-induced platelet aggregation in acute myocardial infarction]. (1999) (16)
- Abciximab not RGD peptide inhibits von Willebrand factor-dependent platelet activation under shear (1999) (16)
- Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial (2014) (15)
- Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis (2014) (15)
- Impact of Carotid Endarterectomy on Medical Secondary Prevention After a Stroke or a Transient Ischemic Attack: Results from the Reduction of Atherothrombosis for Continued Health (REACH) Registry (2006) (15)
- Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease (2009) (15)
- Factor XIa as a possible new target of antithrombotic therapy (2006) (15)
- Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE. (2020) (15)
- Antithrombotic Therapy for Prevention of Various Thrombotic Diseases (2013) (15)
- Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation (2001) (15)
- Adhesive Forces between A1 Domain of von Willebrand Factor and N-terminus Domain of Glycoprotein Ibα Measured by Atomic Force Microscopy. (2015) (14)
- Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease (2020) (14)
- A New Approach to Antiplatelet Therapy: Inhibitor of GPIb/V/IX-vWF Interaction (2001) (14)
- Inhibiting PAR-1 in the prevention and treatment of atherothrombotic events (2010) (14)
- GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke. (2020) (14)
- Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AF. (2016) (13)
- [Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest]. (2003) (13)
- New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF (2019) (13)
- Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality. (2013) (13)
- Platelet Repellent Properties of Hydrogel Coatings on Polyurethane-Coated Glass Surfaces (2014) (13)
- New AI Prediction Model Using Serial PT-INR Measurements in AF Patients on VKAs: GARFIELD-AF. (2019) (13)
- Arterial thrombosis in heart failure (1998) (12)
- Prospective Cohort Study of Gastrointestinal Complications and Vascular Diseases in Patients Taking Aspirin: Rationale and Design of the MAGIC Study (2011) (12)
- Possible mechanism of preventive effects of coffee intake on the formation of arterial occlusive thrombosis. (2010) (12)
- Serial Changes in Coagulant Activities After Thrombolytic Therapy for Acute Myocardial Infarction (1994) (11)
- Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan - Insights From GARFIELD-AF. (2018) (11)
- Regional differences in use of antithrombotic therapy for stroke prevention in atrial fibrillation and associated outcomes: European and Asian insights (2013) (10)
- Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry (2019) (10)
- Net clinical benefit of rivaroxaban versus warfarin in Japanese patients with nonvalvular atrial fibrillation: a subgroup analysis of J-ROCKET AF. (2014) (10)
- Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE (2021) (10)
- Comparative effectiveness of oral anticoagulants in everyday practice (2021) (10)
- Blood constitution: platelet aggregation, bleeding, and involvement of leukocytes. (2008) (9)
- Illustrated State‐of‐the‐Art Capsules of the ISTH 2019 Congress in Melbourne, Australia (2019) (9)
- Targeting thrombin long-term after an acute coronary syndrome: Opportunities and challenges. (2016) (8)
- Outcomes in newly diagnosed atrial fibrillation and history of acute coronary syndromes: insights from GARFIELD-AF. (2019) (8)
- Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials. (2017) (8)
- Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE. (2021) (8)
- Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE (2021) (8)
- Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry (2018) (8)
- Prediction of binding characteristics between von Willebrand factor and platelet glycoprotein Ibα with various mutations by molecular dynamic simulation. (2019) (8)
- The Japan Thrombosis Registry for Atrial Fibrillation, Coronary or Cerebrovascular Events (J-TRACE): a nation-wide, prospective large cohort study; the study design. (2008) (8)
- Searching for Atrial Fibrillation Poststroke (2019) (7)
- Stroke prevention in atrial fibrillation: evidence from real-life studies (2015) (7)
- Clopidogrel and proton pump inhibitors: Gastric protection at expense of vascular benefit? (2009) (7)
- EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN PATIENTS TAKING CONCOMITANT ASPIRIN (2012) (7)
- Serial changes in plasma concentration of plasminogen activator inhibitor-1 before and serially after thrombolytic therapy for acute myocardial infarction. (1993) (7)
- Efficacy and safety of apixaban compared with warfarin for stroke prevention in atrial fibrillation in East Asia (2013) (7)
- Safety of antithrombotic therapy in East Asian patients (2021) (6)
- INAPPROPRIATE UTILIZATION OF ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLOBAL ANTICOAGULANT REGISTRY IN THE FIELD (GARFIELD) REGISTRY (2012) (6)
- The role of trefoil factor family in apparently healthy subjects administrated gastroprotective agents for the primary prevention of gastrointestinal injuries from low-dose acetylsalicylic acid: a preliminary study (2011) (6)
- Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registry. (2021) (6)
- Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE (2018) (6)
- Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50). (2016) (6)
- The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE. (2021) (6)
- High on-treatment platelet reactivity (HPR): What does it mean, and does it matter? (2013) (6)
- Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry (2021) (6)
- Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD‐VTE (2021) (6)
- Persistence and Discontinuation of Oral Anticoagulant: Remaining Issues Not Addressed by Phase III Clinical Trials (2016) (6)
- Possible contribution of acetylamrinone and its enhancing effects on platelet aggregation under shear stress conditions in the onset of thrombocytopenia in patients treated with amrinone. (2003) (6)
- Extracranial arterial and venous thromboembolism in patients with atrial fibrillation: A meta-analysis of randomized controlled trials. (2017) (6)
- GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation (2021) (5)
- Detection of right to left shunting through a patent foramen ovale in Japanese patients with ischemic stroke by transesophageal echocardiography using a standardized Valsalva maneuver. (2005) (5)
- Platelet aggregability under shear is enhanced in patients with unstable angina pectoris who developed acute myocardial infarction. (2001) (5)
- Selection of a suitable patient population for new antiplatelet therapy from the large clinical trial database of the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-thrombolysis in myocardial infarction 50 (TRA-2P-TIMI50) trial. (2015) (5)
- How Can We Avoid a Stroke Crisis in the Asia-Pacific Region? (2011) (5)
- Reexamination of the Embolic Stroke of Undetermined Source Concept (2021) (5)
- Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion: An old question revisited (2011) (5)
- Potential different impact of inhibition of thrombin function and thrombin generation rate for the growth of thrombi formed at site of endothelial injury under blood flow condition. (2019) (5)
- Augmented plasma protein C activity after coronary thrombolysis with urokinase in patients with acute myocardial infarction. (1992) (5)
- Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial. (2019) (4)
- Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study (2019) (4)
- Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study (2019) (4)
- P3569Impact of body mass index in newly diagnosed atrial fibrillation in the GARFIELD-AF registry (2017) (4)
- Application of Neural Networks to 12-Lead Electrocardiography ― Current Status and Future Directions ― (2019) (4)
- Development of Novel Artificial Intelligence to Detect the Presence of Clinically Meaningful Coronary Atherosclerotic Stenosis in Major Branch from Coronary Angiography Video (2020) (4)
- Influence of Body Mass Index on Clinical Outcomes in Venous Thromboembolism: Insights from GARFIELD-VTE. (2021) (4)
- Important Regulatory Roles of Erythrocytes on Platelet Adhesion to the von Willebrand Factor on the Wall Under Blood Flow Conditions. (2021) (4)
- Global Trial or Local One? (2019) (4)
- Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS‐TIMI 54 Trial (2020) (4)
- Progression of systolic dysfunction correlated with the ultrasonographically assessed myocardial tissue damage in patients with dilated cardiomyopathy. (1992) (3)
- Are Japanese patients more prone to gastro-duodenal mucosal injury and bleeding with the use of antiplatelet agents? (2007) (3)
- [Percutaneous transluminal septal ablation with ethanol in hypertrophic obstructive cardiomyopathy: a case report]. (1999) (3)
- No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded Trials. (2020) (3)
- Drug Class, Renal Elimination, and Outcomes of Direct Oral Anticoagulants in Asian Patients: A Meta-Analysis. (2017) (3)
- Thrombosis and antithrombotic therapy Ischaemic risk and efficacy of ticagrelor in relation to time from P 2 Y 12 inhibitor withdrawal in patients with prior myocardial infarction : insights from PEGASUS-TIMI 54 (2016) (3)
- The challenge of monitoring platelet response after clopidogrel. (2008) (3)
- A method and preliminary results of in silico computer simulation for the formation of mix thrombi with platelet and fibrin (2017) (3)
- Acquired von Willebrand Syndrome (AVWS) as an important diagnostic category of disease. (2015) (2)
- [Anesthetic management of patients with neuronal ceroid lipofusucinosis]. (2011) (2)
- POORLY CONTROLLED BLOOD PRESSURE IS INDEPENDENTLY ASSOCIATED WITH A 50% HIGHER RISK OF STROKE OR SYSTEMIC EMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL (2014) (2)
- International normalized ratio control and 1-year outcomes in patients with newly diagnosed atrial fibrillation: the GARFIELD-AF Registry (2014) (2)
- 1354The effect of non-recommended dosing of non-vitamin K antagonist oral anticoagulants (NOACs) on 1-year mortality in patients with newly diagnosed AF? Results from the GARFIELD-AF registry (2018) (2)
- Platelet repellent properties of hydrogel coatings on polyurethane coated glass surfaces (2014) (2)
- Less non-major bleeding with apixaban versus warfarin among patients with atrial fibrillation : insights from the ARISTOTLE trial (2015) (2)
- Abstract 15957: Prospective Assessment of the Relationship Between Use of Evidence-Based Secondary Prevention Therapies and Long-Term (4-Year) Clinical Outcomes in Stable Outpatients With Established Atherothrombotic Disease: Insights from the International REduction of Atherothrombosis for Continue (2011) (2)
- USE OF THE CHADS2 AND CHA2DS2-VASC SCORE IN JAPANESE PATIENTS WITH ATRIAL FIBRILLATION: A SUB-ANALYSIS OF THE JAPAN THROMBOSIS REGISTRY FOR ATRIAL FIBRILLATION, CORONARY OR CEREBROVASCULAR EVENTS (J-TRACE) (2012) (2)
- Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry (2022) (2)
- Validation of DAPT Score (Dual Antiplatelet Therapy) in East Asian Patients (2018) (2)
- Abstract 17121: Reduction in Total Cardiovascular Events With Long-term Use of Ticagrelor in Patients With Prior Myocardial Infarction in the PEGASUS-TIMI 54 Trial (2015) (2)
- Abstract 4022: Control of Cardiovascular Risk Factors in Peripheral Arterial Disease Patients in the REduction in Atherothrombosis for Continued Health (REACH) Registry (2006) (2)
- Abstract 4418: Carotid Endarterectomy versus Carotid Artery Stenting: Insights From a Propensity Matched Analysis of the REduction of Atherothrombosis for Continued Health (REACH) Registry (2009) (2)
- Direct current conversion and clinical events at 1 year in patients with non-valvular atrial fibrillation. The Global Anticoagulant Registry in the FIELD (GARFIELD) (2013) (2)
- [Left atrial booster pump function in left ventricular blood filling: clinical and experimental analyses]. (1991) (2)
- Abstract 18357: Outcomes and Quality of Anticoagulant Control in Patients Newly Diagnosed with Non-valvular Atrial Fibrillation: Insights from the Worldwide GARFIELD Registry (2012) (2)
- Monitoring of the effects of new-generation oral anticoagulants – what does it mean? – . (2012) (2)
- Erratum to: Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study (2013) (2)
- Robust force control of a pantograph system by considering model parameter perturbation (1997) (1)
- Potent antithrombotic treatments in Asian vs. non-Asian patients. (2022) (1)
- [Historical and future perspective of antithrombotic agents]. (2014) (1)
- Editorial comment on 'A novel approach indirectly comparing benefit: risk across oral antithrombotic therapies in patients with atrial fibrillation'. Are the evidences of current dose-adjusted anticoagulation with warfarin stroke prevention for patients with atrial fibrillation sufficient enough to (2015) (1)
- Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy: Insights From the ARISTOTLE Trial. (2021) (1)
- The effect of body mass index on clinical outcomes in patients with newly diagnosed atrial fibrillation in the GARFIELD-AF registry (2020) (1)
- von Willebrand factor-dependent shear-induced platelet aggregation in acute myocardial infarction (1998) (1)
- How can we bridge the results of global clinical trials and region/country specific clinical practice by region/country specific registry data? (2015) (1)
- [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy]. (1993) (1)
- The Future Role of High-Performance Computing in Cardiovascular Medicine and Science -Impact of Multi-Dimensional Data Analysis- (2021) (1)
- Effect of CSL112 (apolipoprotein A‐I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross‐study comparison (2022) (1)
- Physical Characteristics of von Willebrand Factor Binding with Platelet Glycoprotein Ibɑ Mutants at Residue 233 Causing Various Biological Functions (2022) (1)
- Atrial Fibrillation-Related Stroke across the Asia-Pacific Region: A Preventable Problem (2012) (1)
- Vascular Engineering of Blood Coagulation (2016) (1)
- Abstract 9328: Living Alone and Cardiovascular Events in Stable Outpatients at Risk of or with Atherothrombosis: Insight From the REACH Registry (2011) (1)
- Impact of NOAC and VKA on outcome of patients with newly diagnosed atrial fibrillation and diabetes: a report from the GARFIELD-AF registry (2021) (1)
- Computer Simulation of Platelet Adhesion around Stent Struts in the Presence and Absence of Tissue Defects around Them (2021) (1)
- Contributing role of mitochondrial energy metabolism on platelet adhesion, activation and thrombus formation under blood flow conditions (2022) (1)
- [Left ventricular blood filling in patients with severe mitral stenosis: comparisons before and soon after percutaneous transluminal mitral commissurotomy]. (1992) (1)
- Thrombus formation on the catheters inserted in human pulmonary arteries, and its inhibition by anticoagulant and antiplatelet agents (1989) (1)
- P3568Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial (2017) (1)
- Variability of PT-INR values measured by point of care devices INRatio/INRatio 2 and CoaguChek XS and standard laboratory method. A cross-sectional study (2020) (1)
- High rate of death in patients with atrial fibrillation -Results from EORP-AF Pilot General Registry. (2018) (1)
- [Coronary arterial thrombus formation: contributing role of coagulation cascade and fibrinolysis]. (2011) (1)
- Does Computer Simulation Help Facilitate Personalized Precision Medicine for the Use of Warfarin? (2017) (1)
- Abstract 14117: Predictors of Incident Symptomatic Peripheral Arterial Disease in Stable Outpatients: The International REduction of Atherothrombosis for Continued Health (REACH) Registry (2011) (1)
- Letter by Goto and Goto Regarding Article, "Fully Automated Echocardiogram Interpretation in Clinical Practice: Feasibility and Diagnostic Accuracy". (2019) (1)
- Enhancement of Anticoagulant Effect of Warfarin Potassium Following Administration of Paclitaxel and Cisplatin (2009) (1)
- [Low concentrations of epinephrine can augment shear stress-induced platelet aggregation]. (1994) (1)
- Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day (2022) (1)
- Model of Platelet Cell Simulator (2010) (1)
- [Conductance catheter for determining left ventricular volume and end-systolic pressure-volume relations: its clinical application]. (1992) (1)
- Is there a 'therapeutic window' for antiplatelet therapy? (2017) (1)
- A Patient-Level Meta-Analysis: The End of the Era of Direct Oral Anticoagulant Developmental Trials in Patients With Atrial Fibrillation? (2022) (1)
- LONG-TERM RISK AND PROGNOSIS OF RECURRENT CARDIOVASCULAR EVENTS IN THE REACH REGISTRY (2012) (1)
- Platelet Procoagulant Activity Appeared by Exposure of Platelets to Blood Flow Conditions (2008) (1)
- Abstract 3430: Ethnic Differences in the Prevalence and Treatment of Cardiovascular Risk Factors in Outpatients with Peripheral Arterial Disease: Insights from the REACH Registry (2007) (1)
- European physicians don’t like cytoprotective agents? (2011) (1)
- Antithrombotic effects of flavonoid. (2001) (1)
- [Thrombotic tendency in metabolic syndrome]. (2011) (1)
- Force Control in Oscillatory System Using Linear DC Motor : Control System design Based μ-Synthesis (1996) (1)
- PE-077 Risk Stratification of Sudden Death in Patients with Chronic Heart Failure by using Consecutive Late Potential by Holter ECG.(ECG/Body surface potential mapping/Holter(03)(A),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (0)
- OJ-078 Impact of Gender Differences in Prevalence of Risk Factors in Patients with Atrial Fibrillation in Japan : Observations from J-TRACE Study(OJ13,Arrhythmia, Others (Clinical/Diagnosis/Treatment) 1 (A),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation S (2009) (0)
- Platelet GP VI as a New Antiplatelet Target for Prevention of Acute Coronary Syndrome (2003) (0)
- OJ-045 Role of Cholesterol Depletion from Platelet Membrane in Platelet Thrombus Formation on the Matrix Surface under Blood Flow Conditions(Antithrombofic Ttherapy (H) : OJ6)(Oral Presentation (Japanese)) (2004) (0)
- P4601Differences in two-year outcomes according to type of atrial fibrillation: results from the GARFIELD-AF registry (2017) (0)
- OJ-047 Role of ADP Receptors P2Y_1 and P2Y_ in the Maintenance of Stability of Platelet Thrombi under Blood Flow Conditions.(Antithrombofic Ttherapy (H) : OJ6)(Oral Presentation (Japanese)) (2004) (0)
- Relationship between physiological function and metabolism of platelet cell (2014) (0)
- IgG Activaing Platelets under High Shear Stress in Heparin-Induced Thrombocytopenia (2003) (0)
- [Positioning of new generation of oral anticoagulant and good old warfarin]. (2013) (0)
- OJ-224 The Unique Characteristics of Japanese CAD Patients in the Vascular Events : the REduction of Atherothrombosis for Continued Health (REACH) Registry(Preventive medicine/Epidemiology/Education-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
- Corrigendum to “Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE” [Thromb. Res. 2021 May;201:63–72] (2022) (0)
- Sub category : Coronary Heart Disease Angina and Future Cardiovascular Events in Stable Patients with Coronary Artery Disease : Insights from the REACH registry (2016) (0)
- Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF (2022) (0)
- GENDER DIFFERENCES IN CARDIOVASCULAR RISK IN DIABETIC AND NON-DIABETIC OUTPATIENTS AT RISK OF OR WITH ATHEROTHROMBOSIS IN THE REACH REGISTRY (2012) (0)
- What is the meaning of P2Y12 reaction units in patients with essential thrombocythemia? (2015) (0)
- 20719 Adhesive force generation in unfolding VWF molecule (2015) (0)
- EARLY MORTALITY IN PATIENTS WITH NEW ONSET ATRIAL FIBRILLATION: RESULTS FROM THE GARFIELD-AF REGISTRY (2017) (0)
- Abstract 16493: Variation in Patient Characteristics Does Not Explain Regional Differences in Outcomes: Findings From ARISTOTLE (2017) (0)
- CARDIOVASCULAR EVENT RATES IN PATIENTS WITH DIABETES: INSIGHTS FROM THE INTERNATIONAL REACH REGISTRY (2014) (0)
- GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide (2022) (0)
- USEFULNESS OF OXIDIZED-LDL-CHOLESTEROL (MDA-LDL) EVALUATIONS TO ESTIMATE CARDIOVASCULAR ORGAN DAMAGE IN THE EARLY STAGE OF HYPERTENSION AND METABOLIC SYNDROME: PP.19.106 (2011) (0)
- J021023 Numerical study on the platelet aggregation (2013) (0)
- J0102-1-2 Development of Basic Mode1 of Thrombosis Considering Interaction with Platelet (2009) (0)
- 3P-0835 Effects of cholesterol extraction from platelet membrane on the thrombus formation under blood flow conditions (2003) (0)
- Systemic or Venous Thromboembolism Global Anticoagulant Registry in the Field – Venous Thromboembolism ( GARFIELD-VTE ) Rationale and design (2016) (0)
- 1E02 Shear Dependent Adhesive Force between Glycoprotein Ibα and von Willebrand factor and its Conformational Change Measured by Atomic Force Microscopy (2013) (0)
- 236 Influence of Artificial Platelet's Microscopic-motion to the adhesion (2005) (0)
- Coronary artery disease Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure (2014) (0)
- Editorial Comment for the "Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials". Thrombocytopenia as an important complication with the use of antithrombotic agents. (2015) (0)
- FUNCTIONAL REGULATION OF VON WILLEBRAND FACTOR ON THE FORMATION OF PLATELET THROMBI UNDER BLOOD FLOW CONDITION BY ITS SPECIFIC CLEAVING PROTEASE OF ADAMTS13 (2007) (0)
- Abstract 13411: Cigarette Smoking is Associated With a Greater Hazard for Adverse Outcomes in Women Compared With Men: Insights From the Global REACH Registry (2013) (0)
- Cryptogenic stroke prevention through venous thromboembolism prevention: Potential and truth in the advent of non-vitamin K antagonist oral anticoagulants. (2016) (0)
- Limitation of the evidenced based approach in the era of recently developed antithrombotic agents (2012) (0)
- Abstract 14844: Regional Variations on Cardiovascular Outcomes in Stable Chronic Heart Failure Outpatients at Risk of or With Atherothrombosis - Insights From REACH Registry (2015) (0)
- Edoxaban's Journey: From East Asia to the Globe, Back to East Asia. (2018) (0)
- [New therapy with monoclonal antibodies--abciximab, chimeric anti-GP IIb/IIIa antibody]. (2002) (0)
- Effect of Plasma Protein on Shear-Induced von Willebrand Factor-Mediated Platelet Aggregation (1999) (0)
- [Relationship between left ventricular systolic function and the myocardial gray level distribution in patients with idiopathic dilated cardiomyopathy]. (1992) (0)
- 823 Artificial Platelet's transport and adhesion (2005) (0)
- Is the cause of gastric mucosal damage due only to aspirin use? (2013) (0)
- A novel causative gene variant, TNFRSF13B p.Gly76Ser, in patients with pulmonary arterial hypertension (2020) (0)
- ATRIAL FIBRILLATION TREATMENT PARADOX: CHARACTERISTICS OF AND FIRST-YEAR EVENTS IN PATIENTS NOT TREATED WITH VITAMIN-K ANTAGONISTS COMPARED TO TREATED PATIENTS. THE GARFIELD REGISTRY (2013) (0)
- P6009Poor outcomes in pulmonary arterial hypertension as a member of RNF213-associated vascular diseases (2019) (0)
- [Measurement of von Willebrand factor antigen, multimer structure and ristocetin cofactor activities]. (1999) (0)
- [Platelets in coronary thrombosis]. (2016) (0)
- Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination (2023) (0)
- Factors influencing the platelet accumulation around stents (2001) (0)
- On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease (2022) (0)
- Abstract 899: The Impact Of Attained Educational Level On Incident Cardiovascular Events Differs Between High-Income Countries and Low-and-Middle-Income Countries (2009) (0)
- J0206-1-3 Numerical simulation of adhesion/aggregation in platelet thrombus formation (2010) (0)
- Antithrombotic therapy in heart disease (2008) (0)
- Clinical outcomes of patients with newly diagnosed atrial fibrillation who refused anticoagulation: findings from the global GARFIELD-AF registry (2020) (0)
- Device for a power conversion using a switching element (2012) (0)
- Component of a motor vehicle cooling system (2008) (0)
- Component of a motor vehicle cooling system and the heat exchanger (2008) (0)
- An apparatus for controlling a controlled variable by ON / OFF switching operations with less noise (2006) (0)
- Electric power switching device, which produces a reduced noise interference with radio links Mass (2005) (0)
- [Hemostatic effect of epsilon-psilamine administered during surgical operation]. (1966) (0)
- New Trends in Anticoagulant Therapy (2004) (0)
- [Studies on cerebral blood flow under induced hypothermia. 1. Experimental studies on cerebral blood flow determination using nitrous oxide under induced hypothermia]. (1968) (0)
- [Anesthesia for a hemodialysis patient with HIT undergoing CABG using argatroban]. (2012) (0)
- [Anesthetic management of patients with ventricular septal defect with pulmonary hypertension]. (1986) (0)
- [a-ETDCO2 in open heart surgery]. (1985) (0)
- Effect of Higher-Order Structure on Swelling Property in Toluene for Polyphenylene Sulfide (2013) (0)
- P2895Evaluation of the effect of oral anticoagulants on all-cause mortality within 3 months of the diagnosis of atrial fibrillation: results from the GARFIELD-AF prospective registry (2018) (0)
- Understanding of pathophysiology of thrombosis and prediction of the efficacy of medicine using simulation approach (2019) (0)
- Statin Treatment and the Alterations in the Platelet Lipidome: What Is the Impact of Lipid Profile on Thrombosis? (2023) (0)
- Panel Discussion (1997) (0)
- External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry. (2022) (0)
- Important Physical Regulatory Roles of Erythrocytes on Platelet Adhesion Under Blood Flow Conditions. (2021) (0)
- Prediction of polymer melting point using molecular dynamics (2014) (0)
- LIPOSOME-ENCAPSULATED HEMOGLOBIN (TRM645) DOES NOT INTERFERE WITH HUMAN PLATELETS IN EX-VIVO CIRCULATION UNDER A HIGH- AND LOW-FLOW CONDITION (2006) (0)
- Effects of 2,5-furanylene sulfides in polymer main chains on polymer physical properties (2018) (0)
- [von Willebrand factor (antigen and activity), multimer structure, and ristocetin cofactor activity]. (2004) (0)
- Effects of caplacizumab, a specific inhibitor of the A1 domain of von Willebrand factor binding with platelet membrane glycoprotein (GP) Ibα, on the length of platelet pseudopods supporting platelet adhesions on immobilized von Willebrand factor under blood flow condition (2022) (0)
- Abstract 295: Importance of the Rate of Platelet Activation by Thrombin for Regulating the Size of Thrombi Formed Under Low Blood Flow Velocity Conditions (2016) (0)
- Different Physical Parameters in the Bonds between Platelet Glycoprotein Ibα with von Willebrand factor and with Coagulant Factor XI -Results from the Molecular Dynamic Simulation- (2023) (0)
- Detection of the Relationship between the Multi-Dimensional Data Sets of Serially Measured Blood Pressure and the Future Risk of Death in Healthy Elderly Japanese Population. (2022) (0)
- Integrated Computer Simulation Model of the Dynamic Conformational Motion of Intracellular, Transmembrane, and Extracellular Domain of Platelet Integrin α IIbβ 3 (Platelet Membrane Glycoprotein: GPIIb-IIIa) (2022) (0)
- Abstract 770: Potential Explanation of the Mechanism for Loss of Function with G233D Mutation in Platelet Glycoprotein Ibα: Results fromMolecular Dynamics Simulation (2019) (0)
- Abstract 13420: A History of Stable Angina Significantly Increases the Risk of Cardiovascular Death and Myocardial Infarction in the REACH Registry (2011) (0)
- ATOPAXAR AND ITS EFFECTS ON MARKERS OF PLATELET ACTIVATION AND INFLAMMATION: RESULTS FROM THE LANCELOT PROGRAM (2012) (0)
- Is a "pharmacogenomic algorithm" helpful for adjusting the initial dose of warfarin in patients to be treated by warfarin therapy? (2010) (0)
- Abstract 9048: Once-Daily Esomeprazole 20mg Prevents Recurrence of Peptic Ulcer in East Asian Low-Dose Aspirin Users at Gastrointestinal Risk: the LAVENDER Study (2012) (0)
- Negative Hematopoietic Scaffold Lnk Upregulates Integrin Outside-In Signaling in Platelets. (2005) (0)
- 0835 Effect of Biomechanical Environment in Vessel Wall on Stent Restenosis (2010) (0)
- METABOLIC SYNDROME, DIABETES MELLITUS, OR BOTH AND CARDIOVASCULAR RISK IN OUTPATIENTS AT RISK OF OR WITH ATHEROTHROMBOSIS IN THE REACH REGISTRY (2012) (0)
- Heart failure of cor pulmonale dueto chronic respiratory failure (1998) (0)
- Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF (2020) (0)
- Permanent discontinuation of different anticoagulants in patients with atrial fibrillation and the impact on clinical outcome: data from the GARFIELD-AF registry (2020) (0)
- Prolonged activation of fibrinolytic system induced by fibrin nonselective thrombolytic agent can contribute to preventing early reocclusion after coronary thrombolytic therapy. (1993) (0)
- Response to Letter Regarding Article, “Attained Educational Level and Incident Atherothrombotic Events in Low- and Middle-Income Compared With High-Income Countries” (2011) (0)
- Real-time visualization of platelet shape changes occurring in response to their adhesion on immobilized type I collagen or von willebrand factor under controlled blood flow conditions (2003) (0)
- Dissolving Effects of Anti-GP IIb/IIIa Agents (2002) (0)
- 235 mechanical properties of artificial platelet on the adhesive process (2007) (0)
- Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry (2023) (0)
- Mechanism of Platelet Thrombus Formation under Blood Flow Condition. (2006) (0)
- Comparing rivaroxaban and apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria (2021) (0)
- Abstract 207: Vorapaxar in Patients with Prior Ischemic Stroke: Primary Results from the Stroke Cohort of the Multinational TRA 2°P-TIMI 50 Trial (2013) (0)
- Response to “Atrial fibrillation and atherothrombosis: The importance of anticoagulation” by Escobar C and Barrios V (2009) (0)
- Imaging of the Procoagulant Activity Appeared on the Surface of Platelet Thrombi Formed on the Collagen Surface under Flow Conditions (2003) (0)
- Plasma von Willebrand Factor in Patients with Acute Myocardial Infarction (1998) (0)
- Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry (2021) (0)
- [Use of anticoagulant and antiplatelet in general practice]. (2011) (0)
- One-year outcomes in atrial fibrillation patients with versus without coronary artery disease. The prospective Global Anticoagulant registry in the FIELD (GARFIELD) (2013) (0)
- Abstract 17617: History of Bleeding and Outcomes with Apixaban versus Warfarin in Patients with Atrial Fibrillation in the ARISTOTLE Trial (2014) (0)
- Clopidogrel in Atrial Fibrillation: Is There Any Justification Now in the Era of New Anticoagulants? (2012) (0)
- 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. (2022) (0)
- Abstract 19998: Event Rate in Patients with Atrial Fibrillation who Discontinue Oral Anticoagulant Therapy Early: Results from the GARFIELD Registry (2014) (0)
- Twelve-month outcomes in paroxysmal versus permanent atrial fibrillation: data from the prospective, international GARFIELD registry (2013) (0)
- Is the answer to clinical questions provided by Bayesian network meta-analysis? Regarding the optimal duration of DAPT and the best subsequent SAPT (2020) (0)
- Global Clinical Trial (2013) (0)
- Corrigendum to “Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE” [Thromb. Res. 2020 Jul; 191:103–112] (2021) (0)
- Coronary Heart Disease Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes (2011) (0)
- The TIMI Study Group’s Contributions to the Advancement of Cardiology -With Focus on Atherosclerotic Cardiovascular Disease- (2021) (0)
- Safety and efficacy of apixaban and rivaroxaban versus warfarin in real-world atrial fibrillation patients are similar to their randomized trials: insights from GARFIELD-AF registry (2021) (0)
- Role of Chyromicron Remnant in the Progression of Coronary Atherosclerosis (2002) (0)
- [Basic principal of the dual antithrombotic therapy achieved by cilostazol]. (2006) (0)
- [Coronary thrombosis]. (2007) (0)
- [Antithrombotic therapy for acute coronary syndrome]. (2010) (0)
- 0201 Shear dependence on adhesive force of platelet and mechanical property of von Willebrand factor (2010) (0)
- Cardiogenic cerebral infarction: From prevention to acute treatment (2005) (0)
- Erratum: Imaging of Structural Changes in Endothelial Cells and Thrombus Formation at the Site of FeCl3-Induced Injuries in Mice Cremasteric Arteries[Journal of Atherosclerosis and Thrombosis 807-814] (2010) (0)
- [Serial changes in hemostatic molecular markers after urokinase therapy of acute myocardial infarction]. (1992) (0)
- Fluid Analysis for Improvement of a Medical Stent including Adhesion of Blood Cells based on Immersed Boundary Method (2018) (0)
- 20204 Biomechanics of adhesive force generation in VWF molecule (2014) (0)
- Abstract 3525: Targeting Risk Factors To Goals Is Associated With Better Outcomes Among Patients With Coronary Artery Bypass Surgery: Insights From the REACH Registry (2007) (0)
- S1027 The Role of Trefoil Factors (TFF) in Apparently Healthy Subjects Administered Anti-Acid Agents for the Primary Prevention of Gastrointestinal Injuries From Low-Dose Acetylsalicylic Acid (ASA) (2010) (0)
- PJ-734 A Protocol for Surgical Treatment in Paitnets with Drug Eluting Stent Implantation(Coronary revascularization, PCI-19, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
- [New era in thrombolytic therapy for cardiovascular diseases]. (2005) (0)
- [Different inhibiting effects of abciximab and tirofiban on platelet thrombus formation on a collagen surface under flow conditions]. (2000) (0)
- Role Platelet Expressed CD40 Ligand after Exposure to a High Shear Stress on Dendritic Cell Maturation and Activation (2003) (0)
- One-year outcomes in new versus permanent atrial fibrillation: insights from the prospective, international GARFIELD registry (2013) (0)
- [Coronary thrombosis]. (1996) (0)
- [Coronary angioscopy system with PTCA balloon catheter]. (1990) (0)
- 1) Selection of Suitable Antithrombotic Therapy Based upon Precise Pathophysiological Understanding (2015) (0)
- Contributions Of Atrial Level Of Right To Left Communications Detected By Transesophageal Echo Cardiography In The Onset Of lschemic Stroke (2002) (0)
- [GP IIb/IIIa receptor prevention medicine]. (2003) (0)
- Baseline Characteristics of Patients With CAS Versus CEA Before and After Propensity Score Matching Parameter (2010) (0)
- -546- EFFECT OF POSTEXTRASYSTOLIC POTENTIATION ON DETECTING REVERSIBLE ASYNERGY IN ISCHEMIC MYOCARDIUM (1987) (0)
- -462-EFFECTS OF CORONARY ARTERY STENOSIS ON THE CHANGE OF CORONARY DIAMETER DURING NITRATE ADMINISTRATION : Ischemic Heart Disease I : FREE COMMUNICATIONS(II) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1989) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Shinya Goto?
Shinya Goto is affiliated with the following schools:
